Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

LEVOX Lazard US Equity Concentrated Open

  • Fund
  • LEVOX
  • Price as of: Aug 08, 2016
  • $15.22
  • - $0.08
  • - 0.52%
  • Category
  • Large Cap Blend Equities

LEVOX - Profile

Vitals

  • YTD Return 9.3%
  • 3 Yr Annualized Return 14.4%
  • 5 Yr Annualized Return 15.0%
  • Net Assets $1.17 B
  • Holdings in Top 10 62.3%

52 WEEK LOW AND HIGH

$15.22
$12.60
$15.30

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.07%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 74.00%

TRADING FEES

  • Max Redemption Fee 1.00%

Min Investment

STANDARD (TAXABLE)

$2,500

IRA

$2,500

Investment Themes

CATEGORY

Large Cap Blend Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Large Blend

Distributions

  • YTD Total Return 9.3%
  • 3 Yr Annualized Total Return 14.4%
  • 5 Yr Annualized Total Return 15.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.08%
DIVIDENDS
  • Dividend Yield 0.1%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Lazard US Equity Concentrated Portfolio
  • Fund Family Name Lazard
  • Inception Date Sep 30, 2005
  • Shares Outstanding N/A
  • Share Class Other
  • Currency USD
  • Domiciled Country United States
  • Manager Martin Flood

LEVOX - Performance

Return Ranking - Trailing

Period LEVOX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 9.3% -82.7% 66.9% 6.51% 1
1 Yr 9.3% -18.8% 20.8% 5.85% 1
3 Yr 14.4% * -3.8% 21.2% 0.34% 1
5 Yr 15.0% * -1.7% 21.8% 0.55% 1
10 Yr 7.8% * 0.6% 11.3% 15.27% 1

* Annualized


Return Ranking - Calendar

Period LEVOX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 3.1% -58.7% 5.7% 1.93% 1
2014 N/A 0.2% 11.5% N/A N/A
2013 N/A 12.5% 31.1% N/A N/A
2012 N/A 9.2% 16.4% N/A N/A
2011 N/A -3.8% 5.9% N/A N/A

Total Return Ranking - Trailing

Period LEVOX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 9.3% -82.7% 66.9% 6.63% 1
1 Yr 9.3% -21.2% 20.8% 4.62% 1
3 Yr 14.4% * -3.8% 21.2% 0.34% 1
5 Yr 15.0% * -1.7% 21.8% 0.46% 1
10 Yr 7.8% * 0.6% 11.3% 14.10% 1

* Annualized


Total Return Ranking - Calendar

Period LEVOX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 3.1% -58.7% 5.7% 1.92% 1
2014 N/A 2.0% 13.2% N/A N/A
2013 N/A 23.2% 39.5% N/A N/A
2012 N/A 11.6% 23.6% N/A N/A
2011 N/A -2.1% 8.0% N/A N/A

NAV & Total Return History

LEVOX - Holdings

Filings data as of: Jun 30, 2016

Concentration Analysis

LEVOX Category Low Category High LEVOX % Rank Quintile
Net Assets 1.17 B 9.87 K 458 B 11.70% 2
Number of Holdings 21 1 3780 17.05% 5
Net Assets in Top 10 671 M -18.9 K 63.6 B 6.76% 2
Weighting of Top 10 62.3% 0.0% 299.6% 5.18% 1

Top 10 Holdings

  1. Advance Auto Parts Inc 5.14%
  2. Zoetis Inc 8.32%
  3. Pfizer Inc 4.89%
  4. Cisco Systems Inc 7.15%
  5. Kellogg Co 5.37%
  6. Alphabet Inc A 10.80%
  7. Copart Inc 5.94%
  8. Molson Coors Brewing Co B 4.88%
  9. eBay Inc 4.93%
  10. Allergan PLC 4.87%

Asset Allocation

Weighting Category Low Category High LEVOX % Rank Quintile
Stocks
93.19% -0.95% 136.86% 20.53% 4
Cash
6.81% -98.69% 132.07% 5.76% 1
Other
0.00% -81.75% 100.00% 9.50% 4
Convertible Bonds
0.00% 0.00% 85.35% 1.80% 3
Preferred Stocks
0.00% 0.00% 10.32% 3.02% 4
Bonds
0.00% -37.58% 98.94% 5.74% 3

Stock Sector Breakdown

Weighting Category Low Category High LEVOX % Rank Quintile
Consumer Cyclical
31.01% 0.00% 70.69% 0.58% 1
Technology
22.68% 0.00% 51.32% 1.30% 1
Healthcare
18.61% 0.00% 29.64% 3.33% 1
Consumer Defense
17.55% 0.00% 51.54% 1.96% 1
Industrials
3.35% 0.00% 41.49% 27.73% 5
Financial Services
0.00% 0.00% 47.89% 30.20% 5
Energy
0.00% -2.91% 25.38% 26.57% 5
Communication Services
0.00% -0.78% 17.25% 21.36% 5
Real Estate
0.00% -0.11% 11.80% 18.90% 5
Utilities
0.00% -3.20% 25.88% 19.55% 5
Basic Materials
0.00% 0.00% 24.37% 22.09% 5

Stock Geographic Breakdown

Weighting Category Low Category High LEVOX % Rank Quintile
US
93.19% -0.95% 136.86% 16.76% 3
Non US
0.00% -0.69% 94.73% 23.09% 5

LEVOX - Expenses

Operational Fees

LEVOX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.07% 0.02% 303.36% 15.22% 3
Management Fee 0.70% 0.00% 2.25% 2.51% 4
12b-1 Fee 0.25% 0.00% 1.00% 1.99% 2
Administrative Fee 0.02% 0.00% 0.45% 5.50% 1

Sales Fees

LEVOX Fees (% of AUM) Category Low Category High LEVOX Rank Quintile
Front Load N/A 0.00% 5.75% N/A N/A
Deferred Load N/A 0.00% 5.00% N/A N/A

Trading Fees

LEVOX Fees (% of AUM) Category Low Category High LEVOX Rank Quintile
Max Redemption Fee 1.00% 0.15% 2.00% 1.94% 2

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

LEVOX Fees (% of AUM) Category Low Category High LEVOX Rank Quintile
Turnover 74.00% 0.00% 1596.00% 6.89% 4

LEVOX - Distributions

Dividend Yield Analysis

LEVOX Category Low Category High LEVOX % Rank Quintile
Dividend Yield 0.1% 0.00% 11.20% 62.22% 4

Dividend Distribution Analysis

LEVOX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Monthly Annually

Dividend Payout History


Net Income Ratio Analysis

LEVOX Category Low Category High LEVOX % Rank Quintile
Net Income Ratio 0.08% -2.19% 5.26% 17.89% 5

Capital Gain Distribution Analysis

LEVOX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Daily Annually

LEVOX - Managers

Martin Flood

Manager

Start Date

Mar 31, 2011

Tenure

5.34

Tenure Rank

7.1%

"Martin Flood is a Director and Portfolio Manager/Analyst on the Global Equity Select team as well as various US equity strategies, focusing on client communications. In addition, Martin is a Portfolio Manager/Analyst for the US Equity Select (PCG) strategy, which focuses on after-tax returns for private clients. He began working in the investment field in 1993. Prior to joining Lazard in 1996, Martin was a Senior Accountant with Arthur Andersen LLP. He has a BS in accounting from St. John's University. Martin is currently on the Board of Directors for the Cancer Research and Treatment Fund. "


Christopher H. Blake

Manager

Start Date

May 31, 2012

Tenure

4.17

Tenure Rank

8.0%

Christopher Blake Managing Director, Portfolio Manager/Analyst Lazard Asset Management LLC (New York) Christopher Blake is a Portfolio Manager/Analyst on the U.S. Strategic Equity (including the North American Equity Fund, the brand name of the U.S. Strategic Equity offshore fund), U.S. Equity Concentrated and U.S. Mid Cap Equity portfolio teams. He began working in the investment field in 1995 as a Lazard Research Analyst. He has a BSBA in Finance from the University of Denver.


Tenure Analysis

Category Low

0.0

Category High

80.8

Category Average

6.03

Category Mode

1.6